DePuy Synethes Sales, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for DePuy Synethes Sales, Inc.

Sort by

Viewing results 1‒14 of 14

Smith & Nephew PLC
Smith & Nephew in talks to buy NuVasive for over $3bn
...Before Alere, Mr Nawana spent more than 15 years at Johnson & Johnson, including time as president of its DePuy Synthes spine business....
February 8, 2019
Pharmaceuticals sector
Johnson & Johnson slips in first quarter
...The company took unspecified litigation charges, against a backdrop of continuing legal actions including compensation demands from users of its DePuy ASR artificial hip....
April 16, 2013
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Pharmaceuticals sector
Cost cuts bear fruit at Johnson & Johnson
...The company is also facing an onslaught of lawsuits related to faulty hip implants produced by its DePuy unit....
April 17, 2012
World
Doctors call for tougher rules on devices
...The medical devices industry is estimated to generate annual sales of €72bn ($102bn) in Europe alone, from more than 11,000 companies providing 200,000 devices....
May 16, 2011
US downturn
J&J first quarter profits slide 23%
...J&J booked $271m of charges related to its DePuy ASR, a hip replacement which had to be recalled....
April 19, 2011
US healthcare reform
Deal could be cure for Johnson & Johnson
...Last year J&J took after-tax charges of $922m due to lawsuits related to its DePuy ASR replacement hip, which was recalled, and other product liabilities and litigation....
April 18, 2011
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Mergers & Acquisitions
Xstrata leads miners upwards on hopes of Glencore merger
...RBC, which also upgraded the stock to “buy”, said management had been upbeat on aerospace sales in 2011 and reassuring about auto driveline demand....
April 20, 2011
US & Canadian companies
Product recalls weigh on Johnson & Johnson
...Global consumer sales were down 15 per cent in the quarter to $3.6bn....
January 25, 2011
FT AlphavilleNeil Hume
Bid or no bid for Smith & Nephew?
...The companies would also be able to extract synergies from SG&A costs and central functions, as well as leveraging JNJ’s larger sales force to increase sales of Smith & Nephew’s strong hip and knee product...
January 10, 2011
UK economy
Landmark bribery case goes to trial
...J&J admitted in 2007 that it believed non-US subsidiaries had made improper payments linked to medical device sales in two “small-market countries”....
December 1, 2009
UK retail results
Retailers under pressure with fall at Next
...Smith & Nephew dropped 3.2 per cent to 532p after Johnson & Johnson, owner of DePuy Orthopaedics, posted weaker-than-expected quarterly sales....
October 13, 2009
US & Canadian companies
Zimmer faces $450m bill after legal clash
...The case cast a pall over the entire orthopaedics industry, which includes implants and related products such as operating equipment and had sales last year of about $30bn....
May 16, 2008
US downturn
Chief with an impulse for innovation
...And it is a knee made by J&J’s DePuy, of course....
January 13, 2008
US & Canadian companies
Implants give J&J shot in the arm
...Growth in J&J’s medical device business, including its Depuy hip and knee replacement and implant unit, offset the group’s lacklustre pharma business results....
April 19, 2005

Previous pagePage 1 of 1Next page